Accordingly, Jönsson et al. have also demonstrated the loss of WNT5A protein in invasive ductal carcinoma patients, which is in contrast to the expression of WNT5A in DCIS (ductal carcinoma in situ) [8]. This evidence concerns the gene WNT5A and invasive ductal breast carcinoma.